Gross Profit - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xeris Biopharma Holdings Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Gross Profit
$151.9m
CAGR 3-Years
90%
CAGR 5-Years
139%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Gross Profit
$60.1B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$35.4B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Gross Profit
$39.7B
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Gross Profit
$47.4B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$31.4B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
7%

See Also

What is Xeris Biopharma Holdings Inc's Gross Profit?
Gross Profit
151.9m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Gross Profit amounts to 151.9m USD.

What is Xeris Biopharma Holdings Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
139%

Over the last year, the Gross Profit growth was 39%. The average annual Gross Profit growth rates for Xeris Biopharma Holdings Inc have been 90% over the past three years , 139% over the past five years .

Back to Top